These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 25200127)

  • 21. Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI.
    Treaba CA; Granberg TE; Sormani MP; Herranz E; Ouellette RA; Louapre C; Sloane JA; Kinkel RP; Mainero C
    Radiology; 2019 Jun; 291(3):740-749. PubMed ID: 30964421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes.
    Chard DT; Jackson JS; Miller DH; Wheeler-Kingshott CA
    J Magn Reson Imaging; 2010 Jul; 32(1):223-8. PubMed ID: 20575080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.
    Gelineau-Morel R; Tomassini V; Jenkinson M; Johansen-Berg H; Matthews PM; Palace J
    Hum Brain Mapp; 2012 Dec; 33(12):2802-14. PubMed ID: 21976406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.
    Preziosa P; Pagani E; Mesaros S; Riccitelli GC; Dackovic J; Drulovic J; Filippi M; Rocca MA
    Hum Brain Mapp; 2017 Nov; 38(11):5648-5665. PubMed ID: 28792103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of global and regional gray matter volume decrease in multiple sclerosis.
    Grothe M; Lotze M; Langner S; Dressel A
    J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.
    Storelli L; Rocca MA; Pagani E; Van Hecke W; Horsfield MA; De Stefano N; Rovira A; Sastre-Garriga J; Palace J; Sima D; Smeets D; Filippi M;
    Radiology; 2018 Aug; 288(2):554-564. PubMed ID: 29714673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
    Sethi V; Yousry T; Muhlert N; Tozer DJ; Altmann D; Ron M; Wheeler-Kingshott C; Miller DH; Chard DT
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):750-3. PubMed ID: 26272028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
    AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
    Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
    Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.
    Lee H; Nakamura K; Narayanan S; Brown R; Chen J; Atkins HL; Freedman MS; Arnold DL
    Mult Scler; 2018 Jul; 24(8):1055-1066. PubMed ID: 28617152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional brain gray and white matter changes in perinatally HIV-infected adolescents.
    Sarma MK; Nagarajan R; Keller MA; Kumar R; Nielsen-Saines K; Michalik DE; Deville J; Church JA; Thomas MA
    Neuroimage Clin; 2014; 4():29-34. PubMed ID: 24380059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE).
    Futatsuya K; Kakeda S; Yoneda T; Ueda I; Watanabe K; Moriya J; Murakami Y; Ide S; Ogasawara A; Ohnari N; Okada K; Adachi H; Korogi Y
    Magn Reson Med Sci; 2016 Oct; 15(4):349-354. PubMed ID: 26841855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis.
    Bendfeldt K; Blumhagen JO; Egger H; Loetscher P; Denier N; Kuster P; Traud S; Mueller-Lenke N; Naegelin Y; Gass A; Hirsch J; Kappos L; Nichols TE; Radue EW; Borgwardt SJ
    Hum Brain Mapp; 2010 Oct; 31(10):1542-55. PubMed ID: 20108225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
    Lie IA; Kerklingh E; Wesnes K; van Nederpelt DR; Brouwer I; Torkildsen Ø; Myhr KM; Barkhof F; Bø L; Vrenken H
    Eur Radiol; 2022 May; 32(5):3576-3587. PubMed ID: 34978580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automated segmentation of changes in FLAIR-hyperintense white matter lesions in multiple sclerosis on serial magnetic resonance imaging.
    Schmidt P; Pongratz V; Küster P; Meier D; Wuerfel J; Lukas C; Bellenberg B; Zipp F; Groppa S; Sämann PG; Weber F; Gaser C; Franke T; Bussas M; Kirschke J; Zimmer C; Hemmer B; Mühlau M
    Neuroimage Clin; 2019; 23():101849. PubMed ID: 31085465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated tissue segmentation of MR brain images in the presence of white matter lesions.
    Valverde S; Oliver A; Roura E; González-Villà S; Pareto D; Vilanova JC; Ramió-Torrentà L; Rovira À; Lladó X
    Med Image Anal; 2017 Jan; 35():446-457. PubMed ID: 27598104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
    Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
    Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
    Kalinin I; Makshakov G; Evdoshenko E
    AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M; Buck D; Förschler A; Boucard CC; Arsic M; Schmidt P; Gaser C; Berthele A; Hoshi M; Jochim A; Kronsbein H; Zimmer C; Hemmer B; Ilg R
    Mult Scler; 2013 Oct; 19(11):1485-92. PubMed ID: 23462349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Automated detection of white matter and cortical lesions in early stages of multiple sclerosis.
    Fartaria MJ; Bonnier G; Roche A; Kober T; Meuli R; Rotzinger D; Frackowiak R; Schluep M; Du Pasquier R; Thiran JP; Krueger G; Bach Cuadra M; Granziera C
    J Magn Reson Imaging; 2016 Jun; 43(6):1445-54. PubMed ID: 26606758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.